Xeris Biopharma Holdings, Inc. (XERS)
8.475
-0.12
(-1.45%)
USD |
NASDAQ |
Aug 28, 16:00
8.475
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Debt to Equity Ratio : -29.74 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.74 |
| March 31, 2026 | 19.87 |
| December 31, 2025 | 18.85 |
| September 30, 2025 | -299.25 |
| June 30, 2025 | -13.32 |
| March 31, 2025 | -7.651 |
| December 31, 2024 | -9.166 |
| September 30, 2024 | -9.567 |
| June 30, 2024 | -13.99 |
| March 31, 2024 | -29.28 |
| December 31, 2023 | -33.79 |
| September 30, 2023 | 58.98 |
| June 30, 2023 | 16.49 |
| March 31, 2023 | 6.603 |
| December 31, 2022 | 4.383 |
| September 30, 2022 | 2.516 |
| June 30, 2022 | 1.867 |
| March 31, 2022 | 1.427 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.9248 |
| September 30, 2021 | -35.64 |
| June 30, 2021 | 4.398 |
| March 31, 2021 | 1.966 |
| December 31, 2020 | 2.578 |
| September 30, 2020 | 8.328 |
| June 30, 2020 | 4.490 |
| March 31, 2020 | 2.161 |
| December 31, 2019 | 4.039 |
| September 30, 2019 | 1.331 |
| June 30, 2019 | 0.4332 |
| March 31, 2019 | 0.3001 |
| December 31, 2018 | 0.4229 |
| September 30, 2018 | 0.3327 |
| June 30, 2018 | 0.1662 |
| March 31, 2018 | 0.5495 |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Zevra Therapeutics, Inc. | 0.0069 |
| Aclaris Therapeutics, Inc. | 0.0149 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 411.90M |
| Total Liabilities (Quarterly) | 421.64M |
| Shareholders Equity (Quarterly) | -9.734M |
| Current Ratio | 1.449 |
| Net Debt Paydown Yield | -0.30% |